ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Accretion Pharmaceuticals Limited issued a postal ballot notice to shareholders to seek approval for altering the company's Memorandum of Association (Object Clause).
Accretion Pharmaceuticals reported strong FY26 performance with ₹89.63 cr total income and 10.8% PAT margin, driven by export growth.
Accretion Pharmaceuticals Ltd reported revenue from operations of ₹45.9 Cr (+18.3% YoY) and net profit of ₹4.9 Cr (+14.0% YoY) for H2 FY26.